Skip to main content

Find Clinical Trials

Home
Conditions
Hematologic Diseases

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,392 public trials 2,847 recruiting studies

Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Recruiting

Vaccination Against Human Papillomavirus (HPV) After Allogeneic Stem Cell Transplantation

NCT06793410

Conditions: Acute Myeloid Leukaemia, Bone Marrow Diseases, Communicable Diseases, +32 more
Locations: Skåne's University Hospital Lund, Region Skåne, Sweden

Karolinska University Hospital Stockholm, Region Stockholm, Sweden

Uppsala University Hospital Uppsala, Region Uppsala, Sweden

Linköping University Hospital Linköping, Region Östergötaland, Sweden

View Trial Details

Recruiting

Ponatinib in Chronic Myeloid Leukemia Patients in Chronic Phase

NCT06119269

Conditions: Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, Chronic Phase, +12 more
Locations: University of Cagliari - Businco Hospital - Unit of Hematology and Bone Marrow Transplant Cagliari, Italy

Policlinico Milano Milan, Italy

University of Naples Federico II - Unit of Hematology Naples, Italy

Santa Chiara University Hospital Pisa, Italy

View Trial Details

Recruiting

Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia

NCT03104491

Conditions: Acute Lymphocytic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations: The University of Kansas Cancer Center Westwood, Kansas, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

University of Nebraska Medical Center Omaha, Nebraska, United States

Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Recruiting

Blinatumomab Intensification for MRD-Negative Acute B-Cell Lymphoblastic Leukemia Before Allogeneic Hematopoietic Stem Cell Transplantation

NCT07003737

Conditions: Acute Lymphoblastic Leukemia, B-precursor, Hematologic Diseases, Hemic and Lymphatic Diseases, +13 more
Locations: The First Affiliated Hospital of Zhejiang University School of Medicine Hangzhou, Zhejiang, China

View Trial Details

Recruiting

Efficacy and Safety of Sirolimus With or Without Cyclosporin A in Chinese Patients With Aplastic Anemia Refractory/Intolerant to Cyclosporin A

NCT06802055

Conditions: Anemia, Anemia, Aplastic, Aplastic Anaemia, +4 more
Locations: Peking Union Medical College Hospital Beijing, Beijing Municipality, China

View Trial Details

Recruiting

ABBA CORD: dCBT w/ Abatacept for aGVHD Prophylaxis

NCT06680661

Conditions: Acute Lymphatic Leukemia, Acute Myelogenous Leukemia, Bone Marrow Diseases, +28 more
Locations: University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Recruiting

Interferon-α for TP53 Myeloid Malignancy Post Allo-HSCT

NCT06130579

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +6 more
Locations: Deparment of Hematology, Peking University People's Hospital Beijing, Beijing Municipality, China

View Trial Details

Recruiting

A Clinical Study to Evaluate the Safety and Efficacy of CLL1 and CD38 Dual-Target CAR-T Cell Injection in the Treatment of Relapsed or Refractory Acute Myeloid Leukemia

NCT06880354

Conditions: Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: Institute of Hematology & Blood Diseases Hospital, China Tianjin, China

View Trial Details

Recruiting

Impact of Regional Anesthesia on Inflammatory Mechanisms During Vaso-occlusive Crisis in Sickle Cell Patients

NCT07001189

Conditions: Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +12 more
Locations: Chu de La Guadeloupe Pointe-à-Pitre, Guadeloupe

View Trial Details

Recruiting

A Phase I Study to Investigate the Tolerability and Safety of ONO-4685 Given as Monotherapy in T Cell Lymphoma and CLL/SLL

NCT06547528

Conditions: Chronic Disease, Disease Attributes, Hematologic Diseases, +18 more
Locations: Aichi Cancer Center Hospital Nagoya, Aichi-ken, Japan

Nagoya University Hospital Nagoya, Aichi-ken, Japan

Akita University Hospital Akita, Japan

National Cancer Center Hospital East Kashiwa-shi, Chiba, Japan

View all 14 locations

View Trial Details